These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 17240435)

  • 21. Inhibiting the PI3K/Akt pathway reversed progestin resistance in endometrial cancer.
    Gu C; Zhang Z; Yu Y; Liu Y; Zhao F; Yin L; Feng Y; Chen X
    Cancer Sci; 2011 Mar; 102(3):557-64. PubMed ID: 21205080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy.
    Cui X; Schiff R; Arpino G; Osborne CK; Lee AV
    J Clin Oncol; 2005 Oct; 23(30):7721-35. PubMed ID: 16234531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of p21-activated kinase 1 by progestin and its increased expression in the eutopic endometrium of women with endometriosis.
    Kim SH; Lee HW; Kim YH; Koo YH; Chae HD; Kim CH; Lee PR; Kang BM
    Hum Reprod; 2009 May; 24(5):1133-41. PubMed ID: 19168872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas.
    Balañá ME; Lupu R; Labriola L; Charreau EH; Elizalde PV
    Oncogene; 1999 Nov; 18(46):6370-9. PubMed ID: 10597237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of estrogen receptor-alpha in the endometrial carcinoma cell line Ishikawa: inhibition of growth and angiogenic factors.
    Ali SH; O'Donnell AL; Mohamed S; Mousa S; Dandona P
    Gynecol Oncol; 2004 Dec; 95(3):637-45. PubMed ID: 15581976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ER-α36, a novel variant of estrogen receptor α, is involved in EGFR-related carcinogenesis in endometrial cancer.
    Tu BB; Lin SL; Yan LY; Wang ZY; Sun QY; Qiao J
    Am J Obstet Gynecol; 2011 Sep; 205(3):227.e1-6. PubMed ID: 21684519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor expression is not regulated by estradiol or medroxyprogesterone acetate in endometrial carcinoma.
    Kim YB; Berek JS; Martinez-Maza O; Satyaswaroop PG
    Gynecol Oncol; 1996 Apr; 61(1):97-100. PubMed ID: 8626126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer.
    Yang YC; Wu CC; Chen CP; Chang CL; Wang KL
    Gynecol Oncol; 2005 Nov; 99(2):287-93. PubMed ID: 16051341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual-specificity phosphatase 6 predicts the sensitivity of progestin therapy for atypical endometrial hyperplasia.
    Zhang H; Yan L; Bai Y; Li C; Guo Q; Wang C; Zhao X; Li M
    Gynecol Oncol; 2015 Mar; 136(3):549-53. PubMed ID: 25451692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E.
    Kashima H; Shiozawa T; Miyamoto T; Suzuki A; Uchikawa J; Kurai M; Konishi I
    Endocr Relat Cancer; 2009 Mar; 16(1):113-22. PubMed ID: 18852162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endometrial carcinoma remaining after term pregnancy following conservative treatment with medroxyprogesterone acetate.
    Mitsushita J; Toki T; Kato K; Fujii S; Konishi I
    Gynecol Oncol; 2000 Oct; 79(1):129-32. PubMed ID: 11006045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer.
    Jongen V; Briët J; de Jong R; ten Hoor K; Boezen M; van der Zee A; Nijman H; Hollema H
    Gynecol Oncol; 2009 Mar; 112(3):537-42. PubMed ID: 19108875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
    Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
    Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
    Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
    Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermal growth factor ligand/receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer.
    Volante M; Saviozzi S; Rapa I; Ceppi P; Cappia S; Calogero R; Novello S; Borasio P; Papotti M; Scagliotti GV
    Cancer; 2007 Sep; 110(6):1321-8. PubMed ID: 17647268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Endocrinological contribution for invasion and metastasis in gynecological cancers].
    Fujimoto J
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):633-43. PubMed ID: 8808831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
    Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA
    Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response-specific progestin resistance in a newly characterized Ishikawa human endometrial cancer subcell line resulting from long-term exposure to medroxyprogesterone acetate.
    Zhao S; Li G; Yang L; Li L; Li H
    Oncol Lett; 2013 Jan; 5(1):139-144. PubMed ID: 23255909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
    Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of progestin-induced mammary-derived growth hormone in the pathogenesis of cystic endometrial hyperplasia in the bitch.
    Bhatti SF; Rao NA; Okkens AC; Mol JA; Duchateau L; Ducatelle R; van den Ingh TS; Tshamala M; Van Ham LM; Coryn M; Rijnberk A; Kooistra HS
    Domest Anim Endocrinol; 2007 Oct; 33(3):294-312. PubMed ID: 16956744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.